Inhibition of inducible prostaglandin E(2) synthase by 15-deoxy-Delta(12,14)-prostaglandin J(2) and polyunsaturated fatty acids

Biochemical Pharmacology
Omar QuraishiDenis Riendeau

Abstract

Prostaglandin E(2) synthase (PGE synthase) is one of the membrane-associated proteins in the eicosanoid and glutathione metabolism (MAPEG) family of microsomal enzymes and constitutes a novel inducible enzyme involved in inflammation and pyretic responses. We report, using a reversed-phase HPLC assay for the production of tritiated prostaglandin E(2) (PGE(2)) by membranes from cells overexpressing human microsomal PGE synthase, that PGE synthase activity is inhibited effectively by 15-deoxy-Delta(12,14)-prostaglandin J(2) and arachidonic acid. The anti-inflammatory compound 15-deoxy-PGJ(2) was considerably more potent at inhibiting PGE synthase (IC(50)=0.3 microM) than the closely related PGJ(2) or Delta(12)-PGJ(2), or the reaction product PGE(2). Arachidonic acid, docosahexaenoic acid, and eicosapentaenoic acid inhibited PGE synthase with a similar potency (IC(50)=0.3 microM) and were more potent inhibitors than various fatty acid analogues. The present results on the inducible PGE synthase extend observations on the ability to bind arachidonic acid to another member of the MAPEG family, and also suggest a novel mechanism of action for the anti-inflammatory effects of DHA, EPA, and 15-deoxy-PGJ(2).

References

Apr 15, 1989·The Biochemical Journal·W L Smith
Aug 2, 1994·Proceedings of the National Academy of Sciences of the United States of America·B K LamK F Austen
Jan 1, 1993·Archives of Dermatological Research·K DannoS Imamura
Mar 8, 1993·FEBS Letters·J A ManciniP J Vickers
Jun 23, 1999·Proceedings of the National Academy of Sciences of the United States of America·P J JakobssonB Samuelsson
Aug 11, 2000·Prostaglandins & Other Lipid Mediators·K M MaxeyL Hitchingham
May 15, 2001·Biochemical and Biophysical Research Communications·Y TsubouchiH Sano

❮ Previous
Next ❯

Citations

Mar 29, 2007·Journal of Molecular Modeling·Amor A San Juan, Seung Joo Cho
Jun 15, 2005·Bioorganic & Medicinal Chemistry Letters·Denis RiendeauRichard W Friesen
Aug 5, 2003·Prostaglandins, Leukotrienes, and Essential Fatty Acids·William S Powell
Sep 28, 2002·International Immunopharmacology·Xia Zhang, Howard A Young
Aug 18, 2004·Current Opinion in Rheumatology·Hassan Fahmi
Jun 21, 2008·Journal of Gastroenterology and Hepatology·Yoshio YamamotoNaofumi Nagasue
Dec 26, 2003·Nihon yakurigaku zasshi. Folia pharmacologica Japonica·Yoshikazu MiwaToshiyuki Sasaguri
Oct 26, 2011·Future Medicinal Chemistry·Hui-Hua Chang, Emmanuelle J Meuillet
Jun 14, 2008·PPAR Research·Dingzhi Wang, Raymond N Dubois
Nov 19, 2013·Pharmaceutical Patent Analyst·Jessica K NorbergEmmanuelle J Meuillet
May 25, 2005·Fundamental & Clinical Pharmacology·Fumiaki KojimaShinichi Kawai
Jul 22, 2008·British Journal of Pharmacology·H J Leis, W Windischhofer
Jul 30, 2011·The Biochemical Journal·Shan HeLuhua Lai
Jan 23, 2016·Journal of Medicinal Chemistry·Andreas KoeberleOliver Werz
Oct 6, 2009·Biochemical and Biophysical Research Communications·Asako HironakaYasuharu Tanaka
Dec 23, 2016·Medicinal Research Reviews·Catarina Pereira-LeiteSalette Reis
Jun 20, 2017·Expert Opinion on Therapeutic Patents·Anastasia PsarraGeorge Kokotos
Jan 25, 2018·Scientific Reports·Eric Hong Jian WongMun Fai Loke
Mar 1, 2006·Expert Review of Clinical Immunology·Fumiaki KojimaLeslie J Crofford
Oct 22, 2013·Basic & Clinical Pharmacology & Toxicology·Marina Korotkova, Per-Johan Jakobsson
Sep 20, 2007·Pharmacological Reviews·Bengt SamuelssonPer-Johan Jakobsson
Feb 24, 2004·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·J BellengerM Narce
Dec 12, 2003·The American Journal of Clinical Nutrition·Lars C SteneUNKNOWN Norwegian Childhood Diabetes Study Group
May 10, 2016·Journal of Cardiovascular Pharmacology·Oreoluwa O Adedoyin, Charles D Loftin
Jul 16, 2014·Medicinal Research Reviews·Malkeet Singh BahiaPragati Silakari
May 8, 2008·Journal of Medicinal Chemistry·Richard W Friesen, Joseph A Mancini
Jun 13, 2006·Cellular Signalling·Tülay Yucel-LindbergTomomi Kawakami

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here